Health Fund Fights Dismissal Of GSK Copay Coupon Suit

Law360, San Diego (November 21, 2013, 5:40 PM EST) -- A third-party drug purchaser told a Pennsylvania federal judge on Wednesday that its class action alleging GlaxoSmithKline PLC subsidized illegal copayments for brand-name prescription drugs was legitimate, arguing that the pharmaceutical giant had no grounds to seek its dismissal.

The New England Carpenters Health and Welfare Fund emphasized in a 46-page memorandum that it had standing to bring the suit focusing on GSK’s handling of prostate drugs Avodart and Jalyn and triglyceride reducer Lovaza and that the company’s actions were illegitimate.

“GSK’s conduct injures Carpenters and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.